Cited by 453Genetic Neurodegenerative DiseasesGenetics and Neurodevelopmental DisordersAlzheimer's disease research and treatments

A Protein Interaction Network Links GIT1, an Enhancer of Huntingtin Aggregation, to Huntington's Disease

Open access
Goehler, Heike, Lalowski, Maciej, Stelzl, Ulrich, Waelter, Stephanie, Stroedicke, Martin, Worm, Uwe, Droege, Anja, Lindenberg, Katrin S. +16 more·2004·Molecular Cell

Abstract

Analysis of protein-protein interactions (PPIs) is a valuable approach for characterizing proteins of unknown function. Here, we have developed a strategy combining library and matrix yeast two-hybrid screens to generate a highly connected PPI network for Huntington's disease (HD). The network contains 186 PPIs among 35 bait and 51 prey proteins. It revealed 165 new potential interactions, 32 of which were confirmed by independent binding experiments. The network also permitted the functional annotation of 16 uncharacterized proteins and facilitated the discovery of GIT1, a G protein-coupled receptor kinase-interacting protein, which enhances huntingtin aggregation by recruitment of the protein into membranous vesicles. Coimmunoprecipitations and immunofluorescence studies revealed that GIT1 and huntingtin associate in mammalian cells under physiological conditions. Moreover, GIT1 localizes to neuronal inclusions, and is selectively cleaved in HD brains, indicating that its distribution and function is altered during disease pathogenesis.

Integrity signals

Registry

Crossref · 10.1016/j.molcel.2004.09.016

Cites

52 of 52 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Y2H has been used to identify potential modulators of Huntington disease, where interactors of huntingtin might modulate disease severity.

    “This Y2H approach has also been used to identify potential modulators of Huntington disease166, in which it is thought that inter-actors of huntingtin (the causally mutated pathological protein) might modulate disease severity.”

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Goehler, H., Lalowski, M., Stelzl, U., Waelter, S., Stroedicke, M., Worm, U., Droege, A., Lindenberg, K. S., Knoblich, M., Haenig, C., Herbst, M., Suopanki, J., Scherzinger, E., Abraham, C., Bauer, B., Hasenbank, R., Fritzsche, A., Ludewig, A. H., Buessow, K., Coleman, S. H., Gutekunst, C.-A., Landwehrmeyer, B. G., Lehrach, H., & Wanker, E. E.
Affiliations
  • Max Delbrück Center (DE)
  • Max Planck Institute for Molecular Genetics (DE)
  • Universität Ulm (DE)
  • Emory University (US)
Corresponding author
Wanker, Erich E.
Venue
Molecular Cell
Publisher
Elsevier BV
Published
2004-09
Volume
15
Issue
6
Pages
853-865
ISSN
1097-2765 (ISSN-L)
OpenAlex
W2035595951
Cited by
453
References
52
Citations by year
2026: 4 · 2025: 10 · 2024: 8 · 2023: 4 · 2022: 19 · 2021: 13 · 2020: 10 · 2019: 5 · 2018: 14 · 2017: 19 · 2016: 18 · 2015: 20 · 2014: 28 · 2013: 32 · 2012: 37
FWCI
9.96
Type
journal article
Language
en
Open access
Locations
  • Molecular Cell (publishedVersion)
  • PubMed (publishedVersion)
  • MDC Repository (Max-Delbrueck-Center for Molecular Medicine) (submittedVersion)
  • Max Planck Institute for Plasma Physics (submittedVersion)
Funders
National Institute of Neurological Disorders and Stroke (NS31862)
Topics
  • Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Genetic Neurodegenerative Diseases
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetics and Neurodevelopmental Disorders
  • Health Sciences › Medicine › Physiology › Alzheimer's disease research and treatments
Keywords
GIT1, huntingtin aggregation, Huntington's disease, protein-protein interaction network, yeast two-hybrid screen, neuronal inclusions, proteolytic cleavage, huntingtin
MeSH terms
Huntingtin Protein, Amino Acid Sequence, Animals, Antibodies, Monoclonal, Binding Sites, Chlorocebus aethiops, Glutathione, Humans, Huntington Disease, Mice, Transgenic, Nerve Tissue Proteins, Nuclear Proteins, Phosphoproteins, Precipitin Tests, Proline, Protein Binding, Recombinant Fusion Proteins, Tissue Distribution, PC12 Cells, Protein Structure, Tertiary, Cell Cycle Proteins, COS Cells, GTPase-Activating Proteins, Two-Hybrid System Techniques, RNA Interference, Adaptor Proteins, Signal Transducing, Mice, Rats

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review